{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:45:56Z","timestamp":1789105556281,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Resistance to amikacin in Gram-negatives is usually mediated by the 6'-\n                    <jats:italic>N<\/jats:italic>\n                    -acetyltransferase type Ib [AAC(6')-Ib], which catalyzes the transfer of an acetyl group from acetyl CoA to the 6' position of the antibiotic molecule. A path to continue the effective use of amikacin against resistant infections is to combine it with inhibitors of the inactivating reaction. We have recently observed that addition of Zn\n                    <jats:sup>2+<\/jats:sup>\n                    to in-vitro enzymatic reactions, obliterates acetylation of the acceptor antibiotic. Furthermore, when added to amikacin-containing culture medium in complex to ionophores such as pyrithione (ZnPT), it prevents the growth of resistant strains. An undesired property of ZnPT is its poor water-solubility, a problem that currently affects a large percentage of newly designed drugs. Water-solubility helps drugs to dissolve in body fluids and be transported to the target location. We tested a pyrithione derivative described previously (Magda et al. Cancer Res 68:5318\u20135325, 2008) that contains the amphoteric group di(ethyleneglycol)-methyl ether at position 5 (compound 5002), a modification that enhances the solubility. Compound 5002 in complex with zinc (Zn5002) was tested to assess growth inhibition of amikacin-resistant\n                    <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                    and\n                    <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                    strains in the presence of the antibiotic. Zn5002 complexes in combination with amikacin at different concentrations completely inhibited growth of the tested strains. However, the concentrations needed to achieve growth inhibition were higher than those required to achieve the same results using ZnPT. Time-kill assays showed that the effect of the combination amikacin\/Zn5002 was bactericidal. These results indicate that derivatives of pyrithione with enhanced water-solubility, a property that would make them drugs with better bioavailability and absorption, are a viable option for designing inhibitors of the resistance to amikacin mediated by AAC(6')-Ib, an enzyme commonly found in the clinics.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-04724-4","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T06:03:21Z","timestamp":1641535401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Amikacin potentiator activity of zinc complexed to a pyrithione derivative with enhanced solubility"],"prefix":"10.1038","volume":"12","author":[{"given":"Jesus","family":"Magallon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crista L.","family":"Oakley-Havens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0744-8137","authenticated-orcid":false,"given":"Veronica","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9904-7890","authenticated-orcid":false,"given":"Mar\u00eda Soledad","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6298-7811","authenticated-orcid":false,"given":"Marcelo E.","family":"Tolmasky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,7]]},"reference":[{"key":"4724_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.12.041","volume":"538","author":"SM Abuzar","year":"2018","unstructured":"Abuzar, S. M. et al. Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process. Int. J. Pharm. 538, 1\u201313. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.12.041 (2018).","journal-title":"Int. J. Pharm."},{"key":"4724_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/848043","volume":"2013","author":"S Gupta","year":"2013","unstructured":"Gupta, S., Kesarla, R. & Omri, A. Formulation strategies to improve the bioavailability of poorly absorbed drugs with special emphasis on self-emulsifying systems. ISRN Pharm. 2013, 848043. https:\/\/doi.org\/10.1155\/2013\/848043 (2013).","journal-title":"ISRN Pharm."},{"key":"4724_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/2231-4040.82950","volume":"2","author":"VR Patel","year":"2011","unstructured":"Patel, V. R. & Agrawal, Y. K. Nanosuspension: an approach to enhance solubility of drugs. J. Adv. Pharm. Technol. Res. 2, 81\u201387. https:\/\/doi.org\/10.4103\/2231-4040.82950 (2011).","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"4724_CR4","doi-asserted-by":"publisher","DOI":"10.1080\/09205063.2021.1892471","author":"AK Garg","year":"2021","unstructured":"Garg, A. K. et al. Solubility enhancement, formulation development and antifungal activity of luliconazole niosomal gel-based system. J. Biomater. Sci. Polym. Ed. https:\/\/doi.org\/10.1080\/09205063.2021.1892471 (2021).","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"4724_CR5","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/195727","volume":"2012","author":"KT Savjani","year":"2012","unstructured":"Savjani, K. T., Gajjar, A. K. & Savjani, J. K. Drug solubility: importance and enhancement techniques. ISRN Pharm. 2012, 195727. https:\/\/doi.org\/10.5402\/2012\/195727 (2012).","journal-title":"ISRN Pharm."},{"key":"4724_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-021-00953-2","author":"Y Wen","year":"2021","unstructured":"Wen, Y. et al. Azithromycin-loaded linolenic acid-modified methoxy poly(ethylene glycol) micelles for bacterial infection treatment. Drug Deliv. Transl. Res. https:\/\/doi.org\/10.1007\/s13346-021-00953-2 (2021).","journal-title":"Drug Deliv. Transl. Res."},{"key":"4724_CR7","doi-asserted-by":"publisher","first-page":"5318","DOI":"10.1158\/0008-5472.CAN-08-0601","volume":"68","author":"D Magda","year":"2008","unstructured":"Magda, D. et al. Synthesis and anticancer properties of water-soluble zinc ionophores. Cancer Res. 68, 5318\u20135325. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-0601 (2008).","journal-title":"Cancer Res."},{"key":"4724_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22122267","author":"MS Ramirez","year":"2017","unstructured":"Ramirez, M. S. & Tolmasky, M. E. Amikacin: uses, resistance, and prospects for inhibition. Molecules https:\/\/doi.org\/10.3390\/molecules22122267 (2017).","journal-title":"Molecules"},{"key":"4724_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","volume":"13","author":"MS Ramirez","year":"2010","unstructured":"Ramirez, M. S. & Tolmasky, M. E. Aminoglycoside modifying enzymes. Drug Resist. Updat. 13, 151\u2013171. https:\/\/doi.org\/10.1016\/j.drup.2010.08.003 (2010).","journal-title":"Drug Resist. Updat."},{"key":"4724_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fmicb.2013.00121","volume":"4","author":"MS Ramirez","year":"2013","unstructured":"Ramirez, M. S., Nikolaidis, N. & Tolmasky, M. E. Rise and dissemination of aminoglycoside resistance: the aac(6\u2019)-Ib paradigm. Front. Microbiol. 4, 121. https:\/\/doi.org\/10.3389\/fmicb.2013.00121 (2013).","journal-title":"Front. Microbiol."},{"key":"4724_CR11","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.1128\/AAC.01106-15","volume":"59","author":"K Chiem","year":"2015","unstructured":"Chiem, K. et al. Inhibition of aminoglycoside 6\u2019-N-acetyltransferase type Ib-mediated amikacin resistance in Klebsiella pneumoniae by zinc and copper pyrithione. Antimicrob. Agents Chemother. 59, 5851\u20135853. https:\/\/doi.org\/10.1128\/AAC.01106-15 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"4724_CR12","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1128\/AAC.00129-14","volume":"58","author":"DL Lin","year":"2014","unstructured":"Lin, D. L. et al. Inhibition of aminoglycoside 6\u2019-N-acetyltransferase type Ib by zinc: reversal of amikacin resistance in Acinetobacter baumannii and Escherichia coli by a zinc ionophore. Antimicrob. Agents Chemother. 58, 4238\u20134241. https:\/\/doi.org\/10.1128\/AAC.00129-14 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"4724_CR13","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1128\/AAC.00885-15","volume":"59","author":"Y Li","year":"2015","unstructured":"Li, Y., Green, K. D., Johnson, B. R. & Garneau-Tsodikova, S. Inhibition of aminoglycoside acetyltransferase resistance enzymes by metal salts. Antimicrob. Agents Chemother. 59, 4148\u20134156. https:\/\/doi.org\/10.1128\/AAC.00885-15 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"4724_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9020208","author":"MP Cuajungco","year":"2021","unstructured":"Cuajungco, M. P., Ramirez, M. S. & Tolmasky, M. E. Zinc: multidimensional effects on living organisms. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines9020208 (2021).","journal-title":"Biomedicines."},{"key":"4724_CR15","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s002040050096","volume":"68","author":"K Borg-Neczak","year":"1994","unstructured":"Borg-Neczak, K. & Tjalve, H. Effect of sodium pyridinethione on the uptake and distribution of nickel in rats, ferrets and guinea-pigs. Arch. Toxicol. 68, 450\u2013458. https:\/\/doi.org\/10.1007\/s002040050096 (1994).","journal-title":"Arch. Toxicol."},{"key":"4724_CR16","unstructured":"Di, L. & Edward, K. in Drug-like properties: concepts, structure design, and methods Ch. 3, 15\u201328 (Elsevier, Amsterdam, 2008)."},{"key":"4724_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12348-020-00228-w","volume":"10","author":"M Soleimani","year":"2020","unstructured":"Soleimani, M. et al. Current diagnostic tools and management modalities of Nocardia keratitis. J. Ophthalmic Inflamm. Infect. 10, 36. https:\/\/doi.org\/10.1186\/s12348-020-00228-w (2020).","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"4724_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s13054-018-1958-4","volume":"22","author":"A Torres","year":"2018","unstructured":"Torres, A., Motos, A., Battaglini, D. & Li Bassi, G. Inhaled amikacin for severe Gram-negative pulmonary infections in the intensive care unit: current status and future prospects. Crit. Care 22, 343. https:\/\/doi.org\/10.1186\/s13054-018-1958-4 (2018).","journal-title":"Crit. Care"},{"key":"4724_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10010029","author":"CM Reeves","year":"2020","unstructured":"Reeves, C. M. et al. Aminoglycoside 6\u2019-N-acetyltransferase type Ib [AAC(6\u2019)-Ib]-mediated aminoglycoside resistance: phenotypic conversion to susceptibility by silver ions. Antibiotics (Basel) https:\/\/doi.org\/10.3390\/antibiotics10010029 (2020).","journal-title":"Antibiotics (Basel)"},{"key":"4724_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217602","volume":"14","author":"J Magallon","year":"2019","unstructured":"Magallon, J. et al. Restoration of susceptibility to amikacin by 8-hydroxyquinoline analogs complexed to zinc. PLoS ONE 14, e0217602. https:\/\/doi.org\/10.1371\/journal.pone.0217602 (2019).","journal-title":"PLoS ONE"},{"key":"4724_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ijantimicag.2017.08.002","volume":"51","author":"K Chiem","year":"2018","unstructured":"Chiem, K., Hue, F., Magallon, J. & Tolmasky, M. E. Inhibition of aminoglycoside 6\u2019-N-acetyltransferase type Ib-mediated amikacin resistance by zinc complexed with clioquinol, an ionophore active against tumors and neurodegenerative diseases. Int. J. Antimicrob. Agents 51, 271\u2013273. https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.08.002 (2018).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"4724_CR22","doi-asserted-by":"publisher","first-page":"19381","DOI":"10.1038\/s41598-020-76355-0","volume":"10","author":"S Ahmed","year":"2020","unstructured":"Ahmed, S. et al. Retention of antibiotic activity against resistant bacteria harbouring aminoglycoside-N-acetyltransferase enzyme by adjuvants: a combination of in-silico and in-vitro study. Sci. Rep. 10, 19381. https:\/\/doi.org\/10.1038\/s41598-020-76355-0 (2020).","journal-title":"Sci. Rep."},{"key":"4724_CR23","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1016\/j.molonc.2015.05.005","volume":"9","author":"G Srivastava","year":"2015","unstructured":"Srivastava, G. et al. Anticancer activity of pyrithione zinc in oral cancer cells identified in small molecule screens and xenograft model: implications for oral cancer therapy. Mol. Oncol. 9, 1720\u20131735. https:\/\/doi.org\/10.1016\/j.molonc.2015.05.005 (2015).","journal-title":"Mol. Oncol."},{"key":"4724_CR24","doi-asserted-by":"publisher","first-page":"13942","DOI":"10.18632\/oncotarget.14572","volume":"8","author":"C Zhao","year":"2017","unstructured":"Zhao, C. et al. Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases. Oncotarget 8, 13942\u201313956. https:\/\/doi.org\/10.18632\/oncotarget.14572 (2017).","journal-title":"Oncotarget"},{"key":"4724_CR25","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02391-18","author":"L Bohlmann","year":"2018","unstructured":"Bohlmann, L. et al. Chemical synergy between ionophore PBT2 and zinc reverses antibiotic resistance. MBio https:\/\/doi.org\/10.1128\/mBio.02391-18 (2018).","journal-title":"MBio"},{"key":"4724_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb3791","author":"DMP De Oliveira","year":"2020","unstructured":"De Oliveira, D. M. P. et al. Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.abb3791 (2020).","journal-title":"Sci. Transl. Med."},{"key":"4724_CR27","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00157-20","author":"N Harbison-Price","year":"2020","unstructured":"Harbison-Price, N. et al. Multiple bactericidal mechanisms of the zinc ionophore PBT2. mSphere. https:\/\/doi.org\/10.1128\/mSphere.00157-20 (2020).","journal-title":"mSphere."},{"key":"4724_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00194-16","author":"C Blanchard","year":"2016","unstructured":"Blanchard, C. et al. Zinc pyrithione improves the antibacterial activity of silver sulfadiazine ointment. mSphere. https:\/\/doi.org\/10.1128\/mSphere.00194-16 (2016).","journal-title":"mSphere."},{"key":"4724_CR29","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0300-483X(86)90148-4","volume":"38","author":"S Jasim","year":"1986","unstructured":"Jasim, S. & Tjalve, H. Effects of sodium pyridinethione on the uptake and distribution of nickel, cadmium and zinc in pregnant and non-pregnant mice. Toxicology 38, 327\u2013350 (1986).","journal-title":"Toxicology"},{"key":"4724_CR30","doi-asserted-by":"publisher","first-page":"e00212","DOI":"10.1128\/genomeA.00212-15","volume":"3","author":"BA Arivett","year":"2015","unstructured":"Arivett, B. A. et al. Draft genome of the multidrug-resistant Acinetobacter baumannii strain A155 clinical isolate. Genome Announc. 3, e00212-00215. https:\/\/doi.org\/10.1128\/genomeA.00212-15 (2015).","journal-title":"Genome Announc."},{"key":"4724_CR31","doi-asserted-by":"publisher","first-page":"e01190","DOI":"10.1128\/genomeA.01190-14","volume":"2","author":"E Vilacoba","year":"2014","unstructured":"Vilacoba, E. et al. Draft genome sequence of an international clonal lineage 1 Acinetobacter baumannii strain from Argentina. Genome Announc. 2, e01190. https:\/\/doi.org\/10.1128\/genomeA.01190-14 (2014).","journal-title":"Genome Announc."},{"key":"4724_CR32","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1128\/JCM.01264-09","volume":"48","author":"MS Ramirez","year":"2010","unstructured":"Ramirez, M. S. et al. Naturally competent Acinetobacter baumannii clinical isolate as a convenient model for genetic studies. J. Clin. Microbiol. 48, 1488\u20131490. https:\/\/doi.org\/10.1128\/JCM.01264-09 (2010).","journal-title":"J. Clin. Microbiol."},{"key":"4724_CR33","doi-asserted-by":"publisher","first-page":"00168","DOI":"10.1128\/genomeA.00168-13","volume":"1","author":"G Xie","year":"2013","unstructured":"Xie, G. et al. Genome sequences of two Klebsiella pneumoniae Isolates from different geographical regions, Argentina (strain JHCK1) and the United States (strain VA360). Genome Announc. 1, 00168. https:\/\/doi.org\/10.1128\/genomeA.00168-13 (2013).","journal-title":"Genome Announc."},{"key":"4724_CR34","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1128\/AAC.46.11.3422-3427.2002","volume":"46","author":"R Sarno","year":"2002","unstructured":"Sarno, R., McGillivary, G., Sherratt, D. J., Actis, L. A. & Tolmasky, M. E. Complete nucleotide sequence of Klebsiella pneumoniae multiresistance plasmid pJHCMW1. Antimicrob. Agents Chemother. 46, 3422\u20133427. https:\/\/doi.org\/10.1128\/AAC.46.11.3422-3427.2002 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"4724_CR35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1128\/AAC.29.2.315","volume":"29","author":"M Woloj","year":"1986","unstructured":"Woloj, M., Tolmasky, M. E., Roberts, M. C. & Crosa, J. H. Plasmid-encoded amikacin resistance in multiresistant strains of Klebsiella pneumoniae isolated from neonates with meningitis. Antimicrob. Agents Chemother. 29, 315\u2013319 (1986).","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-04724-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-04724-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-04724-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T14:35:48Z","timestamp":1669300548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-04724-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,7]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4724"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-04724-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.10.08.463674","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,7]]},"assertion":[{"value":"29 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"285"}}